activities and sexual intercourse without pain. "Cost-containment" arguments do not impress young, formerly active patients faced with those limitations.
Vascular Response to Hypoxia in Humans
To the Editor:
Drs. Heistad and Abboud emphasize the importance of a vasoconstrictor response to chemoreceptor stimulation as an explanation for the maintenance of systemic blood pressure during hypoxia.' They quote evidence from animal experiments in which regional vasoconstriction was observed during chemoreceptor stimulation.
In our experience and in other reports, minor changes of systemic blood pressure during hypoxia in human subjects have been accompanied by significant increases in cardiac output,2-' and therefore reduction in the calculated total systemic vascular resistance." 4' 7 Although regional vasoconstrictor responses may occur in human subjects, the net effect of hypoxia on the systemic vasculature seems to be vasodilator. Additionally, species differences have been shown with respect to the circulatory adaptation to hypoxia, particularly in anesthetized animal preparations." 7 Therefore, in human subjects during hypoxia, the maintenance of blood pressure is probably related to the increase in cardiac output and not to a vasoconstrictor response mediated by chemoreceptor activity. ROBERTO The author replies: To the Editor:
In our summary of the cardiovascular effects of hypoxemia, we emphasized that the response to hypoxia is the result of several pressor and depressor components. We did mention that the chemoreceptor reflex has pressor effects in humans' as well as animals,2 probably both from vasoconstriction' and increased myocardial contractility.4 As we pointed out, the hyperventilatory response to hypoxia may attenuate or even reverse chemoreceptorinduced vasoconstriction.' The vasodilatation during systemic hypoxia is due in part to a direct effect of hypoxia on vascular muscle.6 Our interpretation of data obtained in both animals and humans is that chemoreceptor-induced vasoconstriction contributes importantly to maintenance of arterial pressure during hypoxia. The thrust of our presentation is to emphasize the multiple mechanisms involved in the response. FRANCOIS with autopsy series, stating, "Previous autopsy studies have reported vegetative valvular lesions in 53% of patients who died of active infective endocarditis.'`However, they misinterpreted the data from these studies.2 3 In fact, all patients in the necropsy studies cited by Stewart et al. had valvular vegetations. The fact that these vegetations were superimposed on previously normal valves in 53% of the cases may be the source of confusion.
The author replies: To the Editor:
We thank Drs. Siegel, Criley and Roberts for their interest in our paper. The point made is well taken and entirely correct. We did indeed inadvertently misinterpret the data from the studies they quote and wish to apologize for this error and any confusion this has caused. JAMES A. STEWART, M.D.
Montreal General Hospital McGill University Montreal, Quebec Canada

Cardiac Denervation with Aortocoronary Bypass
To the Editor: In the article by Bertrand and co-workers (Circulation 61: 877, 1980), the authors describe a technique of denervation of the heart for the treatment of variant angina. Although we have been proponents of sympathetic denervation,' we prefer not to emphasize the pros or cons of sympathectomy in the treatment of angina, but rather the surgical techniques used for denervation of the heart. As indicated by the authors, the diffuse location of the plexi giving rise to the cardiac nerves accounts for the difficulty in achieving a good plexectomy. As they point out, the approach is difficult and bleeding induced by heparinization requires that this procedure be performed before starting bypass. Dangers of incomplete denervation, excessive damage to pulmonary innervation or even denervation of abdominal organs by extrapericardial dissection are obstacles to consistent success. We suggest more specific and simpler techniques for cardiac denervation, whether it be selective in nature or involving total cardiac denervation.
As the authors indicate, cardiac autotransplantation accomplishes denervation of the heart, but this is too complex a procedure and is unwarranted for the proposed objectives. Numerous techniques have been described for the total and partial ablation of cardiac sympathetic efferent nerves. 2 In contrast to the difficulties encountered in performing total cardiac sympathetic denervation, ventricular denervation has been readily accomplished in several ways. We have described a technique for ventricular sympathetic denervation by dissection of the peripulmonary tissues and transection of the ventrolateral cardiac nerve in dogs and have documented depletion of ventricular myocardial catecholamines after this procedure to a level comparable to that found after autotransplantation. 3 We have also accomplished total ventricular denervation by chemical epicardiectomy.' Cardiac denervation and ventricular sympathectomy have been demonstrated to increase the threshold for ventricular fibrillation and other dysrhythmias, decrease mortality and infarct size after coronary occlusion, abolish angina, decrease constrictor tone and increase myocardial blood flow, and contribute to the development of collateral circulation, so we concur with the authors that this procedure may be beneficial in the treatment of variant angina. More recently, we described a technique for total cardiac denervation carried out by intrapericardial dissection accomplished through left thoracotomy or sternotomy.5 Either total or selective cardiac denervation is immediately feasible from this approach. Accordingly, we urge the authors and those who consider cardiac denervation for the treatment of variant angina to pursue these simplified, more easily controlled intrapericardial techniques of cardiac denervation.
